Misuse of the Naranjo Adverse Drug Reaction probability scale in toxicology
Authors:
- 18 June 2013
- journal article
- review article
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 51 (6) , 461-466
Abstract
Context. When an adverse event occurs in an overdose patient, it may be difficult to determine whether the event was caused by the ingested drug or by medical therapy. Naranjo et al. developed a probability scale, the Naranjo Adverse Drug Reaction Probability Scale (Naranjo Scale), to assess the probability that a drug administered in therapeutic doses caused an adverse event thereby classifying the event as an adverse drug reaction (ADR). Although Naranjo et al. specifically excluded the application of this scale to adverse events in overdose patients, case reports demonstrate that authors continue to apply the Naranjo Scale to events in these patients. Objective. The World Health Organization defines an ADR as occurring only when drugs are administered in therapeutic doses. Yet ADRs continue to be reported in overdose patients. We sought to examine the use of the Naranjo scale in case reports of overdose patients to assess the potential consequences of that application. Methods. A Medline search via PubMed without language limits, through September 2012, using the search terms “Naranjo” and “overdose” or “poisoning” yielded 146 publications. Additional searches were performed to find articles with keywords of the Naranjo Scale development, current applications and validity of application in specific populations such as critically ill and overdose patients. Results. From the 146 publications, we identified 17 case reports or case series of overdose patients in which the Naranjo Scale was applied to a clinical complication to support a causal relationship between an administered drug and the clinical complication and thereby classify the clinical complication as an ADR. We also identified a recent publication in which the Naranjo Scale was applied to a new treatment modality (lipid emulsion) that is currently administered to overdose patients. Original publication of the Naranjo Scale and studies evaluating its use in critically ill patients or those with drug-induced disease were also retrieved. Conclusion. Adverse events that occur in overdose patients are excluded from the definition of ADR. Yet in case reports or series of overdose patients, the Naranjo Scale has been applied to assess the probability an event was caused by the ingested drug or therapeutic modality. This application of the Naranjo Scale is not scientifically valid and may lead to erroneous conclusions. There is no evidence to support the application of the Naranjo scale to any events that occur in overdose patients.Keywords
This publication has 26 references indexed in Scilit:
- Hemolysis and Hemolytic Uremic Syndrome following Five-fold N-Acetylcysteine OverdoseClinical Toxicology, 2011
- Coma After Overdose with DuloxetineAnnals of Pharmacotherapy, 2010
- Rhabdomyolysis associated with phentermineAmerican Journal of Health-System Pharmacy, 2010
- Adverse Drug Events Associated with Yohimbine-Containing Products: A Retrospective Review of the California Poison Control System Reported CasesAnnals of Pharmacotherapy, 2010
- Drug-induced liver injury: what was new in 2008?Expert Opinion on Drug Metabolism & Toxicology, 2009
- Evaluation of Naranjo Adverse Drug Reactions Probability Scale in causality assessment of drug‐induced liver injuryAlimentary Pharmacology & Therapeutics, 2008
- Rhabdomyolysis and Necrotic Bowel After Acetaminophen and Ibuprofen OverdosePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2007
- Life-Threatening Interaction Between Complementary Medicines: Cyanide Toxicity Following Ingestion of Amygdalin and Vitamin CAnnals of Pharmacotherapy, 2005
- Reversal of Citalopram‐Induced Junctional Bradycardia with Intravenous Sodium BicarbonatePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2005
- Serotonin Syndrome with Elevated Paroxetine ConcentrationsAnnals of Pharmacotherapy, 2004